Eris Lifesciences partners Natco Pharma to commercialise Semaglutide in India
CDSCO approval enables planned March 2026 launch targeting Type 2 diabetes management
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Natco Pharma
NATCO Pharma and Breckenridge launch Everolimus 1mg generic in the U.S. market
The product is a generic version of Zortress and will be introduced immediately by Breckenridge Pharmaceutical
Natco to launch generic of Risdiplam for SMA patients
The company said it will launch the product immediately, with MRP of ₹15,900
Walking the talk on ESG, workplace safety
Proactively investing in employee and workplace safety is not just good for employees, but makes smart business sense
NATCO Pharma offers to acquire stake in South African Adcock Ingram Holdings
Adcock Ingram generated revenue of R9.6 billion ($ 536 million*) in the financial year June’24 and delivered a gross margin of…
US tariffs, IP issues threaten patient access
The judgements on the Roche Natco case for SMA medicine risdiplam could impact petitions from patients suffering from other rare…
Indian biotech firm develops first indigenous bi-specific 3rd generation CAR T cells for cancer…
Cellogen Therapeutics has secured $2 million in funding from NATCO Pharma and is preparing for clinical trials in collaboration…
NATCO Canada announces $ 8 mn investment in eGenesis
eGenesis is working on a genome engineering-based approach to the development of safe and effective transplantable organs with the…
Fortifying Brand India Pharma
Lessons and insights on measures and approaches to drive innovation, quality and growth in India's pharma sector from industry…
Pee Safe partially closes Series B round with $3 mn from Natco Pharma, Rainmatter Health
The newly acquired funds will be utilised to expand retail presence in India, expand overseas with an omni-channel approach and…